Q/C Technologies, Inc. Deferred Compensation Equity
Q/C Technologies, Inc. (QCLS) had Deferred Compensation Equity of $3.47 thousand as of 2017-12-31, per its 10-K filed 2019-04-01.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:DeferredCompensationEquity · last filed 2019-04-01
- 2017-12-31: Deferred Compensation Equity $3.47K.
- 2017-09-30: Deferred Compensation Equity $8.79K.
- 2017-06-30: Deferred Compensation Equity $14.16K.
- 2017-03-31: Deferred Compensation Equity $19.37K.
| Period end | Deferred Compensation Equity |
|---|---|
| 2017-12-31 | $3.47K 10-K · filed 2019-04-01 |
| 2017-09-30 | $8.79K 10-Q/A · filed 2018-07-13 |
| 2017-06-30 | $14.16K 10-Q/A · filed 2018-07-13 |
| 2017-03-31 | $19.37K 10-Q/A · filed 2018-07-13 |
| 2016-12-31 | $24.57K 10-Q/A · filed 2018-07-13 |
| 2016-09-30 | $29.89K 10-Q · filed 2016-11-14 |
| 2016-06-30 | $36.48K 10-Q · filed 2016-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |